Joseph M. Blondeau ... Oscient Pharmaceuticals, Merck Frosst, Pfizer, Rhone-Poulenc Rorer, Smith-Kline Beecham, Wyeth-Ayerst, YM Biosciences, and Zeneca. Antimicrobial resistance is compromising ...

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate. The company said that ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans for its dedicated oncology division in front of investors, aiming to add eight ...

Pfizer has decided to discontinue the development of another of its experimental obesity therapies, after seeing high rates of discontinuation with the drug in a mid-stage trial. The company is ...

Influenza causes 140,000 to 710,000 hospitalisations and 12,000 to 52,000 deaths in the US every year, as well as economic losses of around $25 billion a year, according to Pfizer.

In another sign of the challenges facing gene therapy developers, Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable.

Showcase your company news with guaranteed exposure both in print and online Gather your employees for an afternoon of games as we honor the Best Places to… Network with our region's hottest ...

Mike Smith is an award-winning editorial cartoonist featured daily in the Las Vegas Sun. Mike's work is syndicated nationally by King Features Syndicate. Read an interview with Mike by his alma ...

CIBC chief market technician warns: ‘We’re going to see much lower levels for the TSX Index’ ...